Latest Breaking News On - Scott bratman - Page 1 : comparemela.com

Adela Presents Data Demonstrating Ability of Tissue-Agnostic MRD Assay to Predict Recurrence in Head & Neck Cancer at the American Association for Cancer Research Annual Meeting 2024

/PRNewswire/ Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide.

United statesGeoffrey liuScientist at princess margaret cancer centreUniversity health networkAdela incPrincess margaret cancer centrePrnewswire adela incAmerican association for cancer researchAmerican associationCancer researchAnnual meetingScott bratmanChief innovation officerRadiation oncologistUniversity healthBoard number

Adela Raises $48M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Lisa aldersonScott bratmanUniversity health network princess margaret cancer centreSinai health systemGenomic healthFoster cityF prime capitalDeerfield managementDecheng capitalChief executive officerGenome medicalChief commercial officerChief strategy officerChief scientific officerDaniel de carvalhoUniversity health network

Adela scores $48M to grow genomic cancer detection platform

The company will use the funds to enrich its technology, commercialize its MRD product and continue the development of its multi-cancer early detection offering.

South koreaTamil naduSouth koreanLisa aldersonScott bratmanShakti ramkissoonIndian institute of technologyUniversity health network princess margaret cancer centreSinai health systemDecheng capitalF prime capitalDeerfield managementDaniel de carvalhoUniversity health networkPrincess margaret cancer centreIndian institute

Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach

Adela Announces $48 Million in Financing and Leadership Addition to Advance Tissue-Agnostic Minimal Residual Disease (MRD) Monitoring Product Portfolio Based on Genome-Wide Methylome Approach
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

Shakti ramkissoonLisa aldersonDavid scheerScott bratmanAdela incSinai health systemUniversity health network princess margaret cancer centreGenomic healthF prime capitalDeerfield managementDecheng capitalChief executive officerChief scientific officerDaniel de carvalhoUniversity health networkPrincess margaret cancer centre

Adela Announces Executive and Board of Directors Appointments and Formation of Scientific Advisory Board

/PRNewswire/ Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments.

United kingdomUniversity collegeNew south walesAndrew elbardissiScott bratmanLisa aldersonSarah jane dawsonSylviak plevritisAllan hackshawChris parkerBrian drukerManeesh jainJames zouGary baderRobert weisskoffPaul brown